Cite
HARVARD Citation
Zhou, Q. et al. (n.d.). 512POsimertinib in advanced or metastatic non-small cell lung cancer patients with EGFR T790M mutation after treatment with EGFR-TKI: Interim analysis of China cohort from the single-arm, open-label, international, multi-center real-world ASTRIS study. Annals of oncology. p. . [Online].